Navigation Links
The 62nd Annual Meeting of the American Association for the Study of Liver Diseases
Date:9/15/2011

SAN FRANCISCO, Sept. 15, 2011 /PRNewswire/ -- The Liver Meeting® is the premier meeting in the science and practice of hepatology, including the latest findings on new drugs, novel treatments, and the results from pilot and multicenter studies.

Approximately 10 percent of Americans have some form of liver disease, but fortunately, the research community has made great strides in recent years in developing new treatments for patients.  

At this year's meeting, 2312 abstracts addressing these issues that will be presented, including 276 abstracts that will be presented in oral sessions. Those abstracts are available to members of the press at our website (www.aasld.org).

San Francisco, CA:  November 5 – 8, 2011

  • Poster Presentations:  November 5 – 8
  • Oral Presentations:  November 6 – 8  

An AASLD President's press conference highlighting key abstracts and issues presented at the Liver Meeting® is scheduled for Saturday, November 5 at 4:00 pm.

Two of this year's programs deal directly with the direct-acting antiviral agents that were recently approved by the FDA.  

  • The Hepatitis C Symposium is designed to educate the provider on newly approved and anticipated therapies for HCV and how these should be integrated into clinical practice.
  • The Hepatitis Debrief is designed to rapidly synthesize and summarize the new data presented at the Liver Meeting® in such a way that the information will be meaningful and useful.

Founded in 1950, AASLD is the leading organization of scientists and healthcare professionals committed to preventing and curing liver disease. AASLD has grown into an international society responsible for all aspects of hepatology, and our annual meeting attracts more than 8,000 physicians, surgeons, researchers, and allied health professionals from around the world.

Please contact AASLD at 703-299-9766 for information about the above presentations, or to receive any additional information about The Liver Meeting® – or visit our website at www.aasld.org.  

Please contact Gregory Bologna to register as press for the meeting: 703-299-9766 or gbologna@aasld.org.

Image to accompany this story: Liver meeting ad

http://www.xpresspress.com/images/liver-meeting.gif

This release was issued through The Xpress Press News Service, merging e-mail and satellite distribution technologies to reach business analysts and media outlets worldwide. For more information, visit http://www.XpressPress.com.


'/>"/>
SOURCE American Association for the Study of Liver Diseases (AASLD)
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Oramed Pharmaceuticals Chosen to Present at the 8th Annual Israel Strategic Partner and Venture Conference on September 22, 2011
2. Alexza Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference
3. Phreesia Unveils New Tool to Help Clinicians Document the Medicare Annual Wellness Visit
4. Intarcia Presents Compelling 48-week Results for ITCA 650 - Data Underlines the Promise to Become the First Injection-free GLP-1 Therapy at the 47th Annual EASD Meeting in Lisbon
5. Regado Biosciences to Present at the Annual UBS Global Life Sciences Conference in New York City
6. Delcath Systems, Inc. Hosts Symposium on Chemosaturation at CIRSE Annual Meeting
7. Savient Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference
8. Emergency Nurses Association Announces Corporate Sponsors for Annual Conference
9. Henry Schein to Present at the CL King 9th Annual Best Ideas Conference 2011
10. Positive Results From Avanafil Phase 3 Study in Diabetics Presented at the 47th EASD Annual Meeting
11. Lexicon Presents LX4211 Clinical Data at European Association for the Study of Diabetes Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... 2016  PipelineRx, a leading medication management technology ... demonstrations of its SaaS-based telepharmacy platform, PowerGridRx™ ... 2016 Midyear Clinical Meeting and Exhibition, December 5-7 ... nearly 300 hospital clients nationally, the Company is ... to dramatically improve pharmacy operations, enhance patient safety, ...
(Date:12/2/2016)... Texas , Dec. 2, 2016  Maxor National Pharmacy ... acquisition of Pharmaceutical Specialties, Inc. ("PSI").  The combination of ... Georgia -based PSI bring together both company,s ... physicians, manufacturers, and payers an industry-leading specialty pharmacy. ... , ...
(Date:12/2/2016)... Dec. 2, 2016 Lianluo Smart Limited ... "the Company") which develops, markets and sells medical ... China and international markets, recently ... and Treatment New Progress Forum, co-hosted by the ... Province , Guangdong Provincial People,s Hospital and ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... December 02, 2016 , ... With the number of ... of an injury, patients must find the one that works for them. When an ... created a machine that worked and decided to share it with others. , He ...
(Date:12/2/2016)... Beverly Hills, CA (PRWEB) , ... December 02, ... ... and reconstructive surgeon in Beverly Hills, California, will be included in the 2016 ... is given to exceptional professionals based on the amalgamation of their education, experience, ...
(Date:12/2/2016)... ... December 02, 2016 , ... Mediaplanet is ... USA Today, which covers the innovative treatments, therapeutic technologies, and revolutionized nutrition that ... “We are prolonging life 6 years in the last 3 decades,” says Dr. ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... Hyatt Regency Waikiki Beach Resort and Spa in Honolulu, offering local frontline clinicians ... of pain management. , The demand for supplemental training related to pain ...
(Date:12/2/2016)... ... December 02, 2016 , ... Sourced from the Isbre Springs beneath the ... its unmatched natural purity of just 6 ppm TDS (Total Dissolved Solids) in addition ... has been available in several ShopRite and FoodTown stores in NJ and received rave ...
Breaking Medicine News(10 mins):